Etuptamig
Etuptamig is a chimeric monoclonal antibody of immunoglobulin λ-chain-γ1, λ-chain-γ3 targeting human natural killer cell cytotoxicity receptor 1 (NCR1) . Etuptamig is promising for research of various cancers[1].
Product Specifications
CAS Number
[3009874-10-3]
UNSPSC
12352203
Target
Others
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Purity
99
Smiles
[Etuptamig]
References & Citations
[1]World Health Organization. WHO Drug Information: Volume 38[M]. World Health Organization, 2024.
Shipping Conditions
Dry Ice
Storage Conditions
-80°C
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS2047235-01 0.1 mL
PE-Linked Polyclonal Antibody to B-Cell Leukemia/Lymphoma 2 (Bcl2)
Ask
View Details MBS2047235-02 0.2 mL
PE-Linked Polyclonal Antibody to B-Cell Leukemia/Lymphoma 2 (Bcl2)
Ask
View Details MBS2047235-03 0.5 mL
PE-Linked Polyclonal Antibody to B-Cell Leukemia/Lymphoma 2 (Bcl2)
Ask
View Details